Gene · 11338
Papers2,147
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,147
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gastric Cancer Cell-Derived Exosomes Induce Macrophage M2 Polarization by Delivering circSMARCC1 to Promote Gastric Cancer Progression. | IUBMB Life | 2025 | 41099193 | PubTator, text mining | PubMed |
| U2AF2 Missense Variant Associated With Epilepsy and Systemic Dysmorphism: Report of Two Cases and Literature Review. | Clin Case Rep | 2025 | 41090043 | PubTator, text mining | PubMed |
| Discovery of the U2AF1-UHM Inhibitor That Possesses Anti-Leukemia Activity In Vitro. | ACS Med Chem Lett | 2025 | 41089473 | PubTator, text mining | PubMed |
| RNAtranslator: Modeling protein-conditional RNA design as sequence-to-sequence natural language translation. | PLoS Comput Biol | 2025 | 41042819 | PubTator, text mining | PubMed |
| HPGD induces ferroptosis and autophagy to suppress esophageal squamous cell carcinoma through the LXA4-ERK1/2-U2AF2-TFRC axis. | Mol Cancer | 2025 | 41039452 | PubTator, text mining | PubMed |
| Integrative analysis of mRNA, lncRNA, circRNA, and miRNA to investigate the anti-fibrotic activity of silibinin in TGF-β2-treated human trabecular meshwork cells. | BMC Genomics | 2025 | 40999359 | PubTator, text mining | PubMed |
| Dynamic U2AF cycling defines two phases of cotranscriptional pre-mRNA splicing. | Science | 2025 | 40997183 | PubTator, text mining | PubMed |
| CKG-TPI: integrating collaborative knowledge graph with sequence interactions for TCR-peptide binding specificity. | Brief Bioinform | 2025 | 40977266 | PubTator, text mining | PubMed |
| Deep indel mutagenesis reveals the regulatory and modulatory architecture of alternative exon splicing. | Nat Commun | 2025 | 40885722 | PubTator, text mining | PubMed |
| OTUB2/NR4A1 restrains the development of preeclampsia by suppressing macrophage M1 polarization. | Commun Biol | 2025 | 40883596 | PubTator, text mining | PubMed |
| Novel role of splicing factor U2AF2 in the tumour microenvironment and its clinical prognostic value: a comprehensive pan-cancer analysis and experimental validation with a focus on COAD. | Int Immunopharmacol | 2025 | 40854264 | PubTator, text mining | PubMed |
| LENG8 mediates RNA nuclear retention and degradation in eukaryotes. | bioRxiv | 2025 | 40832163 | PubTator, text mining | PubMed |
| TRsv: simultaneous detection of tandem repeat variations, structural variations, and short indels using long read sequencing data. | Genome Biol | 2025 | 40830527 | PubTator, text mining | PubMed |
| Phosphoproteomic insights into GFPT2-Associated cellular phospho-signaling networks. | Biochem Biophys Rep | 2025 | 40808719 | PubTator, text mining | PubMed |
| RETRACTION: LncRNA SNHG14 Facilitates Cisplatin Resistance Through Upregulating Notch2 via Binding to U2AF2 in Nasopharyngeal Carcinoma. | Head Neck | 2025 | 40746179 | PubTator, text mining | PubMed |
| Welander distal myopathy-associated TIA1 mutation exacerbates P-body and stress granule dynamics concomitant with nucleolar stress under oxidative stress. | Genes Dis | 2025 | 40735695 | PubTator, text mining | PubMed |
| Pharmacological CLK inhibition disrupts SR protein function and RNA splicing blocking cell growth and migration in TNBC. | Breast Cancer Res | 2025 | 40731028 | PubTator, text mining | PubMed |
| TET dioxygenases localize at splicing speckles and promote RNA splicing. | Nucleus | 2025 | 40717330 | PubTator, text mining | PubMed |
| lncRNA CASC9 stabilizes MUC1 by binding to U2AF2 to inhibit cellular ferroptosis and alleviate LPS-induced cell injury. | Eur J Pharmacol | 2025 | 40490168 | PubTator, text mining | PubMed |
| Construction of a proximity labeling vector to identify protein-protein interactions in human stem cells. | PLoS One | 2025 | 40445938 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11338/papers?page=3